CAR-T cell therapy in India
CAR-T cell therapy in India
Contact Us
Related Videos :
Frequently Asked Questions (FAQ) :
1. What is CAR-T cell therapy, and how does it work?
CAR-T cell therapy is a revolutionary treatment for certain types of cancer, particularly blood cancers like leukemia and lymphoma. It involves modifying a patient’s T-cells (a type of immune cell) in a laboratory to recognize and attack cancer cells. The modified cells, known as Chimeric Antigen Receptor (CAR) T-cells, are then infused back into the patient’s body to target and destroy cancer cells effectively.
2. What types of cancer can be treated with CAR-T cell therapy?
CAR-T cell therapy is primarily used to treat:
- Acute Lymphoblastic Leukemia (ALL)
- Diffuse Large B-cell Lymphoma (DLBCL)
- Follicular Lymphoma
- Mantle Cell Lymphoma
Research is ongoing to expand its use for solid tumors and other cancers.
3. Is CAR-T cell therapy available in India?
Yes, CAR-T cell therapy is now available in select advanced cancer treatment centers in India. It is performed at specialized facilities equipped with the technology and expertise required for this complex procedure. The therapy has been developed and is being adapted to Indian patients’ needs by collaborations between healthcare institutions and biotech companies.
Introduction
Cancer treatment in India has seen groundbreaking advancements, and CAR-T cell therapy is one of the most promising developments. This cutting-edge immunotherapy offers hope to patients battling certain types of cancers, especially those who have not responded well to traditional treatments like chemotherapy or radiation. CAR-T cell therapy is now emerging in India, and with its personalized approach, it has the potential to revolutionize cancer care in the country. Let’s dive into everything you need to know about CAR-T cell therapy, including its cost, procedure, success rates, and more.
What is CAR-T Cell Therapy?
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a form of immunotherapy where a patient’s own immune cells (T-cells) are genetically modified in a lab to better recognize and attack cancer cells. These modified T-cells are then reintroduced into the patient’s body to target and eliminate cancer.
This therapy is primarily used to treat blood cancers like leukemia and lymphoma, and it is particularly beneficial for patients who have not responded to traditional cancer treatments. The personalized nature of CAR-T therapy sets it apart from other treatments, making it a groundbreaking option for cancer patients.
Causes and Risk Factors for CAR-T Cell Therapy Eligibility
While CAR-T cell therapy is an advanced treatment, not every cancer patient is a suitable candidate. The cancers typically treated with CAR-T therapy, such as leukemia and lymphoma, often arise due to genetic mutations, environmental factors, and lifestyle choices. In many cases, patients who have undergone several rounds of chemotherapy or have relapsed may consider CAR-T cell therapy.
Risk factors that determine a patient’s eligibility for CAR-T therapy include:
- Advanced age
- Pre-existing health conditions (e.g., weakened immune systems)
- The stage and type of cancer
- Whether the patient has responded to other cancer treatments
Each patient undergoes a thorough evaluation to assess whether CAR-T therapy is a viable option.
Symptoms of Cancers Treated by CAR-T Therapy
CAR-T cell therapy is typically used to treat patients with blood cancers. Some of the common symptoms of these cancers include:
- Leukemia: Fatigue, frequent infections, unexplained weight loss, bruising, and bone pain
- Lymphoma: Swollen lymph nodes, night sweats, fever, and unexplained weight loss
These cancers often progress rapidly, so early detection and innovative treatments like CAR-T cell therapy can be crucial for achieving remission.
CAR-T Cell Therapy Procedure in India
The procedure for CAR-T cell therapy is complex but highly targeted. Here is an overview of the steps involved:
- T-cell Extraction: First, T-cells are collected from the patient’s blood through a process called leukapheresis.
- Genetic Modification: These T-cells are then sent to a laboratory, where they are genetically modified to produce chimeric antigen receptors (CAR) on their surface. These receptors help the T-cells identify and attack cancer cells more effectively.
- Cell Multiplication: The modified T-cells are multiplied in the lab to produce millions of CAR-T cells.
- Re-infusion: After preparation, the CAR-T cells are re-infused into the patient’s bloodstream, where they begin their work of identifying and destroying cancer cells.
- Post-procedure Monitoring: Patients are closely monitored after the therapy to check for any potential side effects and to ensure that the CAR-T cells are working as intended.
This personalized treatment requires specialized facilities and trained professionals, which is why it is currently available at select hospitals in India.
Cost of CAR-T Cell Therapy in India
The cost of CAR-T cell therapy in India is currently one of the main challenges for widespread accessibility. The therapy involves advanced technology and a personalized approach, making it one of the more expensive cancer treatments available.
- Average Cost: The cost of CAR-T therapy in India can range between ₹30 lakh to ₹50 lakh (approximately $60,000 to $70,000). This is significantly lower than global prices, which can exceed $400,000.
- Factors Influencing Cost: The cost varies depending on the hospital, the complexity of the case, and any additional care or treatment required.
- Insurance and Financial Aid: Some hospitals and medical institutions offer financial aid programs or accept international insurance, which can help reduce the financial burden.
Efforts are being made to lower the costs through clinical trials and collaborations between government and private healthcare sectors.
Success Rate of CAR-T Cell Therapy in India
The success rate of CAR-T cell therapy is one of the most encouraging aspects of this treatment.
- Global Success Rates: CAR-T therapy has shown success rates of up to 80-90% in achieving remission for certain types of leukemia and lymphoma.
- Success in India: Clinical trials in India have also demonstrated high success rates, with many patients achieving remission after receiving CAR-T therapy. The therapy is particularly effective in patients with relapsed or refractory cancer, who have not responded to other treatments.
- Long-term Remission: Many patients have been able to maintain long-term remission, providing hope for those battling aggressive cancers.
Side Effects and Risks of CAR-T Cell Therapy
While CAR-T therapy has shown promising results, it is not without risks. Some of the common side effects include:
- Cytokine Release Syndrome (CRS): A potentially life-threatening condition where the immune system reacts strongly, causing fever, low blood pressure, and difficulty breathing.
- Neurological Side Effects: Some patients may experience confusion, seizures, or speech difficulties.
- Infection Risk: Since CAR-T therapy weakens the immune system, patients are at higher risk of infections.
However, most of these side effects are manageable, especially in hospitals that specialize in CAR-T therapy.
Future of CAR-T Cell Therapy in India
CAR-T cell therapy is still in its early stages in India, but the future looks promising. With ongoing clinical trials and research, the scope of CAR-T therapy is expected to expand beyond blood cancers to include solid tumors like breast and lung cancer.
- Innovations: Third-generation CAR-T cells are being developed to improve efficiency and reduce side effects.
- Increased Accessibility: More hospitals across India are adopting CAR-T therapy, and the government is exploring ways to make this treatment more affordable for a larger segment of the population.
Conclusion
CAR-T cell therapy represents a significant leap forward in cancer treatment, offering hope to patients who previously had limited options. Although the cost and availability are still challenges, the success rate and personalized approach make it a game-changer for cancer care in India. If you or a loved one are considering CAR-T cell therapy, consult with Dr Rahul Bhargava to understand if this treatment is the right option for you.